| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(97)80087-6 |
| P698 | PubMed publication ID | 9048792 |
| P2093 | author name string | K H Lindner | |
| K G Lurie | |||
| A W Prengel | |||
| H U Strohmenger | |||
| B Dirks | |||
| I M Lindner | |||
| P2860 | cites work | Release of endogenous vasopressors during and after cardiopulmonary resuscitation | Q24563142 |
| Stress hormone response during and after cardiopulmonary resuscitation | Q33969185 | ||
| High-dose epinephrine in adult cardiac arrest | Q34330349 | ||
| The Utstein style for uniform reporting of data from out-of-hospital cardiac arrest | Q36775356 | ||
| Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs | Q41439367 | ||
| A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group | Q44322542 | ||
| Vasopressin administration in refractory cardiac arrest. | Q53986250 | ||
| High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. | Q53998905 | ||
| Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. | Q54185791 | ||
| Epinephrine and norepinephrine in cardiopulmonary resuscitation. Effects on myocardial oxygen delivery and consumption | Q68801813 | ||
| Adult advanced cardiac life support: the European Resuscitation Council guidelines 1992 (abridged). European Resuscitation Council Working Party | Q72827726 | ||
| P433 | issue | 9051 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Ventricular Fibrillation | Q848662 |
| epinephrine | Q28163586 | ||
| P304 | page(s) | 535-537 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation | |
| P478 | volume | 349 |
| Q33873042 | 31st Bethesda Conference. Emergency Cardiac Care. Task force 1: cardiac arrest |
| Q44385545 | A comparison of alpha-methylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation |
| Q30307453 | Acute myocardial infarction in the prehospital setting |
| Q43884103 | Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series |
| Q34079013 | Cardiopulmonary and cerebral resuscitation |
| Q74315478 | Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital |
| Q41757504 | Cardiopulmonary resuscitation: a review for clinicians |
| Q36711857 | Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future |
| Q44088780 | Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation |
| Q41985115 | Comparison of two protocols for pulseless cardiopulmonary arrest: vasopressin combined with epinephrine versus epinephrine alone |
| Q35579483 | Current pharmacological advances in the treatment of cardiac arrest |
| Q43596219 | Differences in the pharmacodynamics of epinephrine and vasopressin during and after experimental cardiopulmonary resuscitation |
| Q50859947 | Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. |
| Q26741074 | Drug therapy in cardiac arrest: a review of the literature |
| Q44659642 | Evidence Favoring the Use of an α 2 -Selective Vasopressor Agent for Cardiopulmonary Resuscitation |
| Q36484961 | Evolving role of vasopressin in the treatment of cardiac arrest |
| Q43806376 | Hemodynamic effects of tracheal administration of vasopressin in dogs |
| Q73157036 | Improved cerebral blood supply and oxygenation by aortic balloon occlusion combined with intra-aortic vasopressin administration during experimental cardiopulmonary resuscitation |
| Q43938982 | Is one drug enough? Arginine vasopressin in pediatric cardiopulmonary resuscitation |
| Q37994912 | Is there still a place for vasopressors in the treatment of cardiac arrest? |
| Q44660775 | Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis. |
| Q39103362 | Major publications in the critical care pharmacotherapy literature in 2015. |
| Q33997283 | Management of cardiopulmonary resuscitation |
| Q35048020 | Management of vasodilatory shock: defining the role of arginine vasopressin |
| Q44112178 | New aspects and perspectives on cardiac arrest |
| Q73491758 | Paramedic activities, drug administration and survival from out of hospital cardiac arrest |
| Q30543305 | Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations |
| Q74292358 | Part 10: pediatric advanced life support. European Resuscitation Council |
| Q34026148 | Part 6: advanced cardiovascular life support. Section 6: pharmacology II: agents to optimize cardiac output and blood pressure. European Resuscitation Council |
| Q37200292 | Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations |
| Q35171549 | Pediatric cardiopulmonary-cerebral resuscitation: an overview and future directions |
| Q34531500 | Pressor drugs in the treatment of cardiac arrest |
| Q48594985 | Prolonged cardiopulmonary resuscitation with preservation of cerebral function in an elderly patient with asystole after electroconvulsive therapy |
| Q36960870 | Recent advances and controversies in adult cardiopulmonary resuscitation |
| Q34511286 | Recent advances in emergency life support |
| Q34048472 | Recent progress in advanced cardiac life support |
| Q77718721 | Recommendations of a Task Force of the European Society of Cardiology and the European Resuscitation Council on The Pre-hospital Management of Acute Heart Attacks |
| Q45254488 | Resuscitation after prehospital cardiovascular arrest |
| Q43991943 | Resuscitation from cardiac arrest with adrenaline/epinephrine or vasopressin: effects on intestinal mucosal tonometer pCO(2) during the postresuscitation period in rats |
| Q33752658 | Role of vasopressin in current anesthetic practice |
| Q24805922 | Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology |
| Q77447974 | Splanchnic and renal blood flow after cardiopulmonary resuscitation with epinephrine and vasopressin in pigs |
| Q73453271 | Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs |
| Q77325203 | Synergistic effects of vasopressin plus epinephrine during cardiopulmonary resuscitation |
| Q34130242 | The diagnosis and management of anaphylaxis practice parameter: 2010 Update |
| Q36788352 | Therapeutic potential of vasopressin receptor antagonists. |
| Q58594284 | Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest |
| Q34516598 | Update in pediatric resuscitation |
| Q37340214 | Update on cardiopulmonary resuscitation and emergency cardiovascular care guidelines |
| Q43884109 | Vasopressin and epinephrine are equally effective for CPR in a rat asphyxia model |
| Q77385866 | Vasopressin and epinephrine for cardiac arrest |
| Q34999221 | Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future? |
| Q77447969 | Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs |
| Q34564289 | Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study |
| Q37714346 | Vasopressin in the pediatric cardiac intensive care unit: Myth or reality |
| Q43681668 | Vasopressin or epinephrine: which initial vasopressor for cardiac arrests? |
| Q72999049 | Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery |
| Q36548321 | Vasopressin treatment of verapamil toxicity in the porcine model |
| Q44918802 | Vasopressin versus epinephrine during cardiopulmonary resuscitation: a randomized swine outcome study |
| Q34084513 | Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. |
| Q44120490 | Vasopressin with delayed combination of nitroglycerin increases survival rate in asphyxia rat model |
| Q86948276 | [Out-of-hospital emergency medicine in Germany, Austria and Switzerland : randomized prospective studies from 1990 to 2012] |
| Q79385637 | [Utility of vasopressin in cardiopulmonary resuscitation] |
Search more.